These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32271165)

  • 21. Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid.
    Rother A; Glander P; Vitt E; Czock D; von Ahsen N; Armstrong VW; Oellerich M; Budde K; Feneberg R; Tönshoff B; Weber LT
    Eur J Clin Pharmacol; 2012 Jun; 68(6):913-22. PubMed ID: 22274404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors: a patent and scientific literature review (2002-2016).
    Cuny GD; Suebsuwong C; Ray SS
    Expert Opin Ther Pat; 2017 Jun; 27(6):677-690. PubMed ID: 28074661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of IMPDH1 is regulated in response to mycophenolate concentration.
    Bremer S; Vethe NT; Rootwelt H; Bergan S
    Int Immunopharmacol; 2009 Feb; 9(2):173-80. PubMed ID: 19010451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel series of non-nucleoside inhibitors of inosine 5'-monophosphate dehydrogenase with immunosuppressive activity.
    Franklin TJ; Morris WP; Jacobs VN; Culbert EJ; Heys CA; Ward WH; Cook PN; Jung F; Plé P
    Biochem Pharmacol; 1999 Sep; 58(5):867-76. PubMed ID: 10449198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
    Jayaram HN; Cooney DA; Grusch M; Krupitza G
    Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.
    Chiarelli LR; Molinaro M; Libetta C; Tinelli C; Cosmai L; Valentini G; Dal Canton A; Regazzi M
    Br J Clin Pharmacol; 2010 Jan; 69(1):38-50. PubMed ID: 20078611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex.
    Theilmann W; Gericke B; Schidlitzki A; Muneeb Anjum SM; Borsdorf S; Harries T; Roberds SL; Aguiar DJ; Brunner D; Leiser SC; Song D; Fabbro D; Hillmann P; Wymann MP; Löscher W
    Neuropharmacology; 2020 Dec; 180():108297. PubMed ID: 32890589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolic acid displays IMPDH-dependent and IMPDH-independent effects on renal fibroblast proliferation and function.
    Petrova DT; Brandhorst G; Brehmer F; Gross O; Oellerich M; Armstrong VW
    Ther Drug Monit; 2010 Aug; 32(4):405-12. PubMed ID: 20592645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
    Vethe NT; Bergan S
    Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inosine-5'-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells.
    Metz S; Holland S; Johnson L; Espling E; Rabaglia M; Segu V; Brockenbrough JS; Tran PO
    Endocrinology; 2001 Jan; 142(1):193-204. PubMed ID: 11145582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
    Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
    Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of the inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
    Cholewiński G; Iwaszkiewicz-Grześ D; Prejs M; Głowacka A; Dzierzbicka K
    J Enzyme Inhib Med Chem; 2015; 30(4):550-63. PubMed ID: 25198892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IMPDH as a biological probe for RNA antiviral drug discovery: synthesis, enzymology, molecular docking, and antiviral activity of new ribonucleosides with surrogate bases.
    Nair V; Ma X; Shu Q; Zhang F; Uchil V; Cherukupalli GR
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):651-4. PubMed ID: 18066873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and application of a high-performance liquid chromatography-based assay for determination of the activity of inosine 5'-monophosphate dehydrogenase in whole blood and isolated mononuclear cells.
    Albrecht W; Storck M; Pfetsch E; Martin W; Abendroth D
    Ther Drug Monit; 2000 Jun; 22(3):283-94. PubMed ID: 10850395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and biological evaluation of novel inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
    Dunkern T; Chavan S; Bankar D; Patil A; Kulkarni P; Kharkar PS; Prabhu A; Goebel H; Rolser E; Burckhard-Boer W; Arumugam P; Makhija MT
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):408-19. PubMed ID: 23663081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A putative role for inosine 5' monophosphate dehydrogenase (IMPDH) in Leishmania amazonensis programmed cell death.
    Pitaluga AN; Moreira ME; Traub-Csekö YM
    Exp Parasitol; 2015 Feb; 149():32-8. PubMed ID: 25499513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
    Vethe NT; Bremer S; Bergan S
    Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
    Digits JA; Hedstrom L
    Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of the mycophenolate-inhibited form of IMP dehydrogenase in vivo.
    McPhillips CC; Hyle JW; Reines D
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12171-6. PubMed ID: 15292516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid.
    Sintchak MD; Fleming MA; Futer O; Raybuck SA; Chambers SP; Caron PR; Murcko MA; Wilson KP
    Cell; 1996 Jun; 85(6):921-30. PubMed ID: 8681386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.